• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

UNC:GR

59.430 EUR 1.566 2.71%

As of 02:06:50 ET on 04/23/2014.

Snapshot for UCB SA (UNC)

Open: 59.422 Day's Range: 58.930 - 59.430 Volume: 0
Previous Close: 57.864 52wk Range: 38.115 - 59.430 1-Yr Rtn: +29.41%

Stock Chart for UNC

No chart data available.
  • UNC:GR 59.420
  • 1D
  • 1M
  • 1Y
57.864
Interactive UNC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for UNC

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 29.3917
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) 2.0220
Est. PEG Ratio 2.0590
Market Cap (M EUR) 11,559.47
Shares Outstanding (M) 194.51
30 Day Average Volume 79
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.74%
Cash Dividend (EUR) 0.7800
Dividend Ex-Date 04/29/2014
5 Year Dividend Growth 2.09%
Next Earnings Announcement 07/31/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for UNC

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for UNC

UCB SA is a biopharmaceutical company. The Company specializes in the treatment of central nervous system disorders, inflammatory diseases, and oncology. UCB operates worldwide.

Roch F DoliveuxChief Executive OfficerJean-Christophe TellierExec VP:Biopharma/CEO-Elect
Detlef ThielgenExec VP/CFOIsmail KolaExec VP/Pres:Newmedicines
More Company Profile & Key Executives for UNC

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil